[PDF][PDF] Treatments for metastatic hormone-sensitive prostate cancer: systematic review, network meta-analysis and benefit-harm assessment
S Sivec Muñiz - 2021 - zora.uzh.ch
… -sensitiven Prostatakrebs (metastatic hormone-sensitive prostate … survival benefit overall
and in the high-volume mHSPC subgroup, but a statistically significant benefit in the low-volume …
and in the high-volume mHSPC subgroup, but a statistically significant benefit in the low-volume …
Where do we stand in the management of oligometastatic prostate cancer? A comprehensive review
GR Juan, FH Laura, PV Javier, VC Natalia… - Cancers, 2022 - mdpi.com
… tumour, metastasis directed therapy or systemic therapy, to … that are not high volume are
defined as low volume M1 disease. … progression-free survival (PFS) and distant metastasis-free …
defined as low volume M1 disease. … progression-free survival (PFS) and distant metastasis-free …
[PDF][PDF] New Drug Approvals in Prostate Cancer and Their Effect on the Treatment Landscape
C Jani, N Abdallah, P Chrysafi… - … in Hematology & …, 2023 - hematologyandoncology.net
… systemic treatment for patients with metastatic hormone-sensitive … low-volume prostate
cancer (HR, 1.04; 95% CI, 0.50-0.79), there was a significant benefit for patients with high-volume …
cancer (HR, 1.04; 95% CI, 0.50-0.79), there was a significant benefit for patients with high-volume …
History of Prostate Cancer Over the Last 50 Years.
L Schimke - Urologic Nursing, 2019 - search.ebscohost.com
… and no immediate onset systemic aller gic reaction, unlike … High-volume disease was
defined as visceral metastases or … strated overall survival in lowvolume metastatic hormone-sen …
defined as visceral metastases or … strated overall survival in lowvolume metastatic hormone-sen …
METASTATSKI HORMON-OSJETLJIVI KARCINOM PROSTATE–ODABIR ADT PARTNERA.
M MLADINOVIĆ, M Gnjidić, B Belev - Lijecnicki Vjesnik, 2023 - search.ebscohost.com
… for high-risk, high-volume, and low-volume disease. A significant … a benefit in progression-free
survival (PFS) and overall survival (… Novel androgen axis systemic therapies for metastatic …
survival (PFS) and overall survival (… Novel androgen axis systemic therapies for metastatic …
[PDF][PDF] NOVE mETODE pRObIRA zA RANO OTkRIVANjE RAkA kOLOREkTumA New screening methods for early colorectal cancer detection
E VRKLJAN, I Petrović, P Matošević, I Romić, G Pavlek… - hrcak.srce.hr
… died of massive haematuria despite systemic treatment. … treatment for metastatic STS
disease for most subtypes is chemotherapy based on antracyclines with a median overall survival …
disease for most subtypes is chemotherapy based on antracyclines with a median overall survival …